OtherJun 6, 2026, 06:35 AM
Reid Hoffman leaves Microsoft board to go 'founder mode' with startup Manus
Summary
After a profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus. Hoffman, co-founder of LinkedIn and early investor in OpenAI, joined Microsoft's board in 2017. During his tenure, Microsoft's market value surged. Manus uses AI to accelerate drug development, and Hoffman says he will fully engage in 'founder mode'.
Why it matters
Hoffman's departure from Microsoft's board to focus on AI drug discovery startup Manus highlights the trend of tech leaders shifting from big companies to AI startups.
Source links
⚠ Content is from official & reputable-media public sources, AI-assisted and auto-published, for information only — not investment advice.
Market reaction
The following is market reference information for related companies, and does not constitute investment advice.
Microsoft
NASDAQ · MSFT